These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 9501066)
21. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration. Meng F; Lowell CA EMBO J; 1998 Aug; 17(15):4391-403. PubMed ID: 9687507 [TBL] [Abstract][Full Text] [Related]
22. Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src. Verderame MF; Guan JL; Woods Ignatoski KM Mol Biol Cell; 1995 Aug; 6(8):953-66. PubMed ID: 7579711 [TBL] [Abstract][Full Text] [Related]
23. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544 [TBL] [Abstract][Full Text] [Related]
24. Role of Gas1 down-regulation in mitogenic stimulation of quiescent NIH3T3 cells by v-Src. Grossi M; La Rocca SA; Pierluigi G; Vannucchi S; Ruaro EM; Schneider C; Tatò F Oncogene; 1998 Oct; 17(13):1629-38. PubMed ID: 9796692 [TBL] [Abstract][Full Text] [Related]
25. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 2: hydroxyindole derivatives. Milkiewicz KL; Marsilje TH; Woodworth RP; Bifulco N; Hangauer MJ; Hangauer DG Bioorg Med Chem Lett; 2000 Mar; 10(5):483-6. PubMed ID: 10743953 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Whitesell L; Mimnaugh EG; De Costa B; Myers CE; Neckers LM Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8324-8. PubMed ID: 8078881 [TBL] [Abstract][Full Text] [Related]
27. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src. Nakaigawa N; Weirich G; Schmidt L; Zbar B Oncogene; 2000 Jun; 19(26):2996-3002. PubMed ID: 10871851 [TBL] [Abstract][Full Text] [Related]
28. Ubiquitin-mediated degradation of active Src tyrosine kinase. Harris KF; Shoji I; Cooper EM; Kumar S; Oda H; Howley PM Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13738-43. PubMed ID: 10570142 [TBL] [Abstract][Full Text] [Related]
29. Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family. Langlais P; Dong LQ; Hu D; Liu F Oncogene; 2000 Jun; 19(25):2895-903. PubMed ID: 10871840 [TBL] [Abstract][Full Text] [Related]
30. The mechanism of cell cycle regulation by v-Src. Riley D; Carragher NO; Frame MC; Wyke JA Oncogene; 2001 Sep; 20(42):5941-50. PubMed ID: 11593401 [TBL] [Abstract][Full Text] [Related]
31. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function. Brickell PM Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720 [TBL] [Abstract][Full Text] [Related]
32. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: hydroxynaphthalene derivatives. Marsilje TH; Milkiewicz KL; Hangauer DG Bioorg Med Chem Lett; 2000 Mar; 10(5):477-81. PubMed ID: 10743952 [TBL] [Abstract][Full Text] [Related]
33. Chemical genetic strategy for targeting protein kinases based on covalent complementarity. Garske AL; Peters U; Cortesi AT; Perez JL; Shokat KM Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15046-52. PubMed ID: 21852571 [TBL] [Abstract][Full Text] [Related]
34. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Schlaepfer DD; Hanks SK; Hunter T; van der Geer P Nature; 1994 Dec 22-29; 372(6508):786-91. PubMed ID: 7997267 [TBL] [Abstract][Full Text] [Related]
35. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437 [TBL] [Abstract][Full Text] [Related]
36. Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Xing Z; Chen HC; Nowlen JK; Taylor SJ; Shalloway D; Guan JL Mol Biol Cell; 1994 Apr; 5(4):413-21. PubMed ID: 8054685 [TBL] [Abstract][Full Text] [Related]
37. A general strategy for producing conditional alleles of Src-like tyrosine kinases. Spencer DM; Graef I; Austin DJ; Schreiber SL; Crabtree GR Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9805-9. PubMed ID: 7568222 [TBL] [Abstract][Full Text] [Related]
38. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Amundadottir LT; Leder P Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037 [TBL] [Abstract][Full Text] [Related]
39. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design. Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358 [TBL] [Abstract][Full Text] [Related]
40. Magic bullets for protein kinases. Bishop AC; Buzko O; Shokat KM Trends Cell Biol; 2001 Apr; 11(4):167-72. PubMed ID: 11306297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]